passages.id: split_8_test_1610_passage
passages.type: progene_text
passages.text: We treated patients with B-NHL with Rituxan , a chimeric CD20 mAb , and observed abrogation of staining not only with prototype CD20 mAb B-1 but also with mAb FMC7 .